BEVERLY, Mass., Aug. 2, 2011 /PRNewswire/ -- Enzymatics, Inc., (www.enzymatics.com) a leading biotech manufacturing company, has been honored by the Greater Boston Chamber of Commerce with a "Top 10 Small Business" of the year award for 2011.
Honorees include dynamic small and high growth businesses in Greater Boston that have demonstrated strong financial performance, workplace excellence, product innovation, and social responsibility. An awards luncheon will be held to honor these businesses October 13, 2011 at the Colonnade Hotel in Boston, MA.
"We've seen incredible growth in just five short years, and that comes from a lot of hard work," said Enzymatics co-founder and president Christopher Benoit. "It's a great boost for our team to receive this award and have their dedication and innovation recognized."
As of this summer, the Beverly-based biotech firm was in the process of expanding its headquarters, opening a European office, and adding 15 new full-time positions to its existing staff of 50.
Beyond employee contributions, co-founder and CEO Stephen Picone gives a nod to the region's biotech community for helping foster company success: "Thanks to sound investment, good policy, and all the forward-thinking business leaders that operate in our space, Massachusetts has become an international center for biotech manufacturing. This has been an ideal place for us to do business, and we'd like to thank all our customers and the regional partners who helped fuel our growth."
The Chamber's Small Business of the Year Awards is now in its 27th year of recognizing the achievements of the top ten businesses. "The 2011 winners are an excellent representation of the entrepreneurial spirit, focus on excellence and commitment to the community that define our region's small businesses," said Paul Guzzi, president and CEO of the Greater Boston Chamber of Commerce. "We look forward to honoring them."
ABOUT ENZYMATICS: Enzymatics is a leading biotechnology and biosciences manufacturing company that delivers ISO 13485-compliant enzymes of unrivaled purity, consistency, and value to the healthcare and bioscience industries. Headquartered in Beverly, Massachusetts, the company adheres to a customer-as-partner business model and also leverages key institutional licensing agreements in order to commercialize breakthrough biotechnologies. Enzymatics currently ships products to over 20 countries. For more information please visit www.enzymatics.com.
Contact: Lisa Lazarczyk, lazPR
SOURCE Enzymatics, Inc.